EP Patent

EP4181930A1 — Ocular insert containing a glucocorticoid

Assigned to Ocular Therapeutix Inc · Expires 2023-05-24 · 3y expired

What this patent protects

In certain embodiments, the invention relates to a sustained release biodegradable intracanalicular insert containing a glucocorticoid dispersed in a hydrogel for the treatment of dry eye disease.

USPTO Abstract

In certain embodiments, the invention relates to a sustained release biodegradable intracanalicular insert containing a glucocorticoid dispersed in a hydrogel for the treatment of dry eye disease.

Drugs covered by this patent

Patent Metadata

Patent number
EP4181930A1
Jurisdiction
EP
Classification
—
Expires
2023-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Ocular Therapeutix Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.